Screener
Neuropace, Inc. NPCE Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s current ratio?
- Neuropace, Inc. (NPCE) reported current ratio of 4.9× in Q2 2026.
- How has Neuropace, Inc.'s current ratio changed year-over-year?
- Neuropace, Inc.'s current ratio decreased by 9.6% year-over-year, from 5.5× to 4.9×.
- What is the long-term trend for Neuropace, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s current ratio has grown at a -1.5% compound annual growth rate (CAGR), from 5.7× to 5.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Neuropace, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude